FMO5 and endothelial dysfunction: Sustained activation of ATIR leads to anion superoxide (O2−) overproduction from NADPH oxidase which in turn is responsible for the reduction of bioavailability of the endothelium-derived nitric oxide (NO·) and then for the endothelial dysfunction [18, 19].